Share:
Share this content in WeChat
X
Experience Exchanges
The diagnostic value of short T1 signal and ADC value in benign and malignant ovarian lesions
MENG Li  DU Jianing  SHAREN Gaowa  BAO Haihua 

Cite this article as: Meng L, Du JN, Sharen GW, et al. The diagnostic value of short T1 signal and ADC value in benign and malignant ovarian lesions[J]. Chin J Magn Reson Imaging, 2022, 13(3): 83-86. DOI:10.12015/issn.1674-8034.2022.03.017.


[Abstract] Objective To investigate the magnetic resonance signal characteristics of benign and malignant ovarian lesions with short T1 signal and the diagnostic value of apparent diffusion coefficient (ADC) value.Materials and Methods A total of 42 patients with benign and malignant ovarian lesions confirmed by surgery and pathology in the Affiliated Hospital of Qinghai University from Jun 2019 to Jun 2020 were selected and their T1WI images were analyzed. Imaging signs were observed and the maximum diameter, ADC value, tumor location, boundary, cystic firmness, cystic wall/space, and T1 signal uniformity were measured to compare the differences between the two groups.Results There were 52 T1 hypersignal lesions in 42 patients. Among them, 39 lesions were benign, including 16 endometriosis cysts, 10 mature cystic teratoma, 7 luteal cysts, 4 mucinous cystadenoma, 1 white body and 1 follicular cyst with hemorrhage. Thirteen lesions were malignant, including 11 serous cystadenocarcinoma, 1 clear ovarian cell carcinoma and 1 granulosa cell tumor. There were statistically significant differences in the maximum diameter, ADC value, capsule wall/space, cyst consolidation and T1 signal uniformity between benign and malignant lesions (P<0.05).Conclusions Magnetic resonance imaging has a certain value in differential diagnosis of benign and malignant ovarian lesions with short T1 signal, and the accuracy of preoperative determination of ovarian lesions can be improved by mastering the MR characteristics.
[Keywords] ovarian lesions;magnetic resonance imaging;short T1 signal;apparent diffusion coefficient;pathological type

MENG Li   DU Jianing   SHAREN Gaowa   BAO Haihua*  

Affiliated Hospital Imaging Department of Qinghai University, Xining 810001, China

Bao HH, E-mail: baohelen2@sina.com

Conflicts of interest   None.

ACKNOWLEDGMENTS Qinghai Province Health System Appropriate Technology Promotion Project (No. 2020-wjzdx-56)
Received  2021-08-03
Accepted  2022-03-07
DOI: 10.12015/issn.1674-8034.2022.03.017
Cite this article as: Meng L, Du JN, Sharen GW, et al. The diagnostic value of short T1 signal and ADC value in benign and malignant ovarian lesions[J]. Chin J Magn Reson Imaging, 2022, 13(3): 83-86. DOI:10.12015/issn.1674-8034.2022.03.017.

[1]
Wei MX, Bai GJ, Guo LL. The research progress of radiomics in ovarian tumors[J]. Chin J Magn Reson Imaging, 2020, 11(5): 386-389. DOI: 10.12015/issn.1674-8034.2020.05.016.
[2]
Xu HY. MRI diagnosis of benign ovarian cystic lensions and its clinical value[J]. J Anhui Heal Vocat Tech Coll, 2021, 20(1): 43-44, 47.
[3]
Yue YM, Cheng G, Feng JY. Magnetic resonance imaging-diffusion weighted imaging in diagnosis of benign and malignant ovarian tumors[J]. Oncol Prog, 2021, 19(1): 53-55, 80. DOI: 10.11877/j.issn.1672-1535.2021.19.01.14.
[4]
Guo JJ. Comparison of the application of diffusion kurtosis imaging and DWI in the differential diagnosis of benign and malignant ovarian lesions[J]. Chin Imaging J Integr Tradit West Med, 2021, 19(2): 140-142. DOI: 10.3969/j.issn.1672-0512.2021.02.011.
[5]
Guillerman RP, Foulkes WD, Priest JR. Imaging of DICER1 syndrome[J]. Pediatr Radiol, 2019, 49(11): 1488-1505. DOI: 10.1007/s00247-019-04429-x.
[6]
Pulappadi VP, Manchanda S, SK P, et al. Identifying corpus luteum rupture as the culprit for haemoperitoneum[J]. Br J Radiol, 2021, 94(1117): 20200383. DOI: 10.1259/bjr.20200383.
[7]
Qian LD, Wu H, Gao Y, et al. Application of different DWI models in the diagnosis of ovarian tumors[J]. Chin J Magn Reson Imaging, 2019, 10(10): 797-800. DOI: 10.12015/issn.1674-8034.2019.10.017.
[8]
Pian WT, Zhang DZ, Jia FY, et al. The MR signal analysis of ovarian benign lesions with T1 hyperintense[J]. Chin J CT & MRI, 2017, 15(9): 108-110, 148. DOI: 10.3969/j.issn.1672-5131.2017.09.033.
[9]
Bonnin A, Durot C, Djelouah M, et al. MR imaging of the perihepatic space[J]. Korean J Radiol, 2021, 22(4): 547-558. DOI: 10.3348/kjr.2019.0774.
[10]
Chapron C, Vannuccini S, Santulli P, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach[J]. Hum Reprod Update, 2020, 26(3): 392-411. DOI: 10.1093/humupd/dmz049.
[11]
Seagle BLL, Ann P, Butler S, et al. Ovarian granulosa cell tumor: a National Cancer Database study[J]. Gynecol Oncol, 2017, 146(2): 285-291. DOI: 10.1016/j.ygyno.2017.05.020.
[12]
Wang S, Zhao HF. CT and MRI findings of ovarian granulosa cell tumor[J]. J Pract Radiol, 2017, 33(9): 1397-1400. DOI: 10.3969/j.issn.1002-1671.2017.09.019.
[13]
Sakala MD, Shampain KL, Wasnik AP. Advances in MR imaging of the female pelvis[J]. Magn Reson Imaging Clin N Am, 2020, 28(3): 415-431. DOI: 10.1016/j.mric.2020.03.007.
[14]
Huang DP, Lin HM, Liu ZS, et al. Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma[J]. Radiol Pract, 2020, 35(11): 1464-1468. DOI: 10.13609/j.cnki.1000-0313.2020.11.018.
[15]
Canellas R, Rosenkrantz AB, Taouli B, et al. Abbreviated MRI protocols for the abdomen[J]. Radiographics, 2019, 39(3): 744-758. DOI: 10.1148/rg.2019180123.
[16]
Marko J, Marko KI, Pachigolla SL, et al. Mucinous neoplasms of the ovary: radiologic-pathologic correlation[J]. Radiographics, 2019, 39(4): 982-997. DOI: 10.1148/rg.2019180221.
[17]
Rockall AG. Diffusion weighted MRI in ovarian cancer[J]. Curr Opin Oncol, 2014, 26(5): 529-535. DOI: 10.1097/CCO.0000000000000112.
[18]
Shetty M. Nonovarian mimics of ovarian malignancy[J]. Semin Ultrasound CT MR, 2019, 40(4): 319-331. DOI: 10.1053/j.sult.2019.04.003.
[19]
Flicek KT, VanBuren W, Dudiak K, et al. Borderline epithelial ovarian tumors: what the radiologist should know[J]. Abdom Radiol (NY), 2021, 46(6): 2350-2366. DOI: 10.1007/s00261-020-02688-z.
[20]
Li Y, Zhang Y, Hu ZH. Application of MRI in diagnosis and differentiation of benign ovarian lesions[J]. Chin J CT & MRI, 2020, 18(10): 125-127. DOI: 10.3969/j.issn.1672-5131.2020.10.037.
[21]
Gadducci A, Guerrieri ME, Cosio S. Squamous cell carcinoma arising from mature cystic teratoma of the ovary: a challenging question for gynecologic oncologists[J]. Crit Rev Oncol Hematol, 2019, 133: 92-98. DOI: 10.1016/j.critrevonc.2018.10.005.

PREV Utility of delta ADC value to differentiate uterine carcinosarcoma from endometrial carcinomas
NEXT The diagnostic value of magnetic resonance imaging in rib micro-fractures
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn